Sign in

CIK 0001719714

  • Non-accelerated filer
  • Smaller reporting company

Mereo BioPharma Group plc

Sign in to watch
Ticker
MREO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 3330237300
Business address
ONE CAVENDISH PLACE, FOURTH FLOOR, LONDON, United Kingdom, W1G 0QF
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-26 Shames Daniel Director Grant or award · Share Options (Right to buy) +66,000 66,000
2026-02-26 Shames Daniel Director Grant or award · Deferred Restricted Stock Units +96,163 96,163
2025-02-05 Shames Daniel Director Grant or award · Share Options (Right to buy) +55,000 55,000
2025-02-05 Shames Daniel Director Grant or award · Deferred Restricted Stock Units +13,719 13,719
2024-02-08 Shames Daniel Director Grant or award · Share Options (Right to buy) +45,000 45,000
2024-02-08 Shames Daniel Director Grant or award · Deferred Restricted Stock Units +14,139 14,139

Page 1 of 1 · 6 trades